Sm. Halliday et al., INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION BY THE SULFONATED STILBENE DYE RESOBENE, Antiviral research, 33(1), 1996, pp. 41-53
The anti-HIV sulfonated dye, resobene, was found to be a potent inhibi
tor of the attachment of HIV to target cells, the fusion of envelope-
and CD4-expressing cells, and the cell-to-cell transmission of virus.
Resobene inhibited the infection of phenotypically distinct, establish
ed human cell lines and fresh human peripheral blood lymphocytes and m
acrophages by laboratory-derived isolates of human immunodeficiency vi
rus type 1 (HIV-1) and type 2 (HIV-2), and a panel of biologically div
erse primary clinical isolates, including syncytium-inducing and non-s
yncytium-inducing viruses and strains representative of the various vi
rus clades found worldwide. The compound was also active against all d
rug-resistant virus isolates tested. Cell-based and biochemical mechan
ism of action studies demonstrated that the compound inhibits the atta
chment of infectious virus and fusion of virus-infected cells to uninf
ected target cells by binding to the cationic V3 loop of the envelope
glycoprotein. Resobene effectively inhibited the infection of cell pop
ulations which do and do not express cell surface CD4. Resobene preven
ted infection of the cervical epithelial cell line ME180, suggesting t
he compound may effectively act as a topical microbicide to prevent th
e sexual transmission of HIV.